Kei Muro

36PUBLICATIONS
179CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursMolecular targetsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Sep 21, 2026
Early-onset chemotherapy-induced neutropenia and ascites control in patients with severe peritoneal metastasis of gastric cancer: a post hoc analysis of the JCOG1108/WJOG7312G trial.

|Aug 27, 2026
Phase II study of mFOLFOX6 in advanced gastric cancer patients with severe peritoneal metastases (WJOG10517G), including an individual patient data comparison with JCOG1108/WJOG7312G.

|May 05, 2026
Enfortumab Vedotin plus Pembrolizumab as First-line Treatment in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Results from EV-202 Cohort 9.

|Apr 13, 2026
Development of a visualization tool to estimate out-of-pocket costs for systemic cancer therapy in Japan and claims-based agreement evaluation: the VEST-Ca study.

Kazunori Honda, Kazuhiro Shimomura, Hiroya Taniguchi

|Apr 03, 2026
Survival in Patients With Low Expression of Wild-Type Homologous Recombination Genes: Refining the Homologous Recombination Paradigm in Colorectal Cancer.

Daniel Walden, Felipe Batalini, Cody Eslinger

|Mar 06, 2026
Impact of prior immune checkpoint inhibitor on trastuzumab deruxtecan in HER2-positive advanced gastric cancer: exploratory analysis of the EN-DEAVOR study.

Yukiya Narita, Hisato Kawakami, Koki Nakanishi

Pageof 6

Frequent Collaborators

9 joint publications

Yukiya Narita

5 joint publications

Hisato Kawakami

4 joint publications

Hiroki Hara

4 joint publications

Takeshi Kawakami